BPTB Versus Hamstring Autografts in ACL Reconstruction Among Professional Athletes
BPTB-HT ACL
Bone-Patellar Tendon-Bone Versus Hamstring Tendon Autografts in ACL Reconstruction Among Professional Athletes: A Prospective Randomized Controlled Study With Mid-term Follow-up
1 other identifier
interventional
65
1 country
1
Brief Summary
This prospective randomized controlled study compares outcomes of ACL reconstruction using bone-patellar tendon-bone (BPTB) versus hamstring tendon (HT) autografts in professional athletes. The primary outcome is isokinetic muscle strength assessment. Secondary outcomes include IKDC score, return to athletic activity, and complication rates. Patients are followed for five years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedFirst Submitted
Initial submission to the registry
April 30, 2026
CompletedFirst Posted
Study publicly available on registry
May 7, 2026
CompletedMay 7, 2026
May 1, 2026
7.4 years
April 30, 2026
May 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Isokinetic Quadriceps and Hamstring Muscle Strength
Isokinetic dynamometric assessment of quadriceps and hamstring muscle strength expressed as peak torque percentage relative to the contralateral limb using a standardized testing protocol.
12 months postoperatively
Secondary Outcomes (4)
International Knee Documentation Committee (IKDC) Score
12 months postoperatively
Time to Return to Athletic Activity
Up to 12 months postoperatively
Postoperative Complications
Up to 60 months postoperatively
Knee function using KOOS score
60 months postoperatively
Study Arms (2)
BPTB Group
EXPERIMENTALParticipants undergoing ACL reconstruction using bone-patellar tendon-bone (BPTB) autograft.
Hamstring Group
ACTIVE COMPARATORParticipants undergoing ACL reconstruction using hamstring tendon autograft (semitendinosus and gracilis).
Interventions
Arthroscopic anterior cruciate ligament reconstruction using bone-patellar tendon-bone autograft with interference screw fixation.
Arthroscopic anterior cruciate ligament reconstruction using semitendinosus and gracilis tendon autograft with appropriate fixation technique.
Eligibility Criteria
You may qualify if:
- Professional athletes actively engaged in competitive sports
- Age between 18 and 35 years
- Primary isolated anterior cruciate ligament (ACL) rupture confirmed clinically and by MRI
- Indicated for arthroscopic ACL reconstruction
- Willingness to participate and provide informed consent
You may not qualify if:
- Multiligamentous knee injuries
- Previous ACL reconstruction on the affected knee
- Lower limb malalignment
- Advanced chondral lesions requiring additional surgical procedures
- Associated fractures around the knee
- Inability to comply with follow-up protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
- Kasr Al-Ainy Hospitalscollaborator
Study Sites (1)
Kasr Al-Ainy Hospital, Cairo University
Cairo, Cairo Governorate, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Orthopedic Surgery
Study Record Dates
First Submitted
April 30, 2026
First Posted
May 7, 2026
Study Start
February 1, 2018
Primary Completion
June 30, 2025
Study Completion
June 30, 2025
Last Updated
May 7, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share